• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA25-100/I16-40
Device Problems Collapse (1099); Leak/Splash (1354); Off-Label Use (1494)
Patient Problem Failure of Implant (1924)
Event Date 03/06/2018
Event Type  Injury  
Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
On (b)(6) 2018, endologix was made aware from a rep regarding a patient with a possible type 3 endoleak between afx main body and aortic extension from a post op 1 month follow up ct.In addition, patient was also noted for a possible type ia endoleak in the anterior portion of the aorta in which it appeared that there was no adhesion of the cuff to the vessel wall; and a possible collapse of the proximal portion of the aortic extension towards the posterior aorta.Images were attached for further evaluation with the third image as most impressive, where they can see that the cuff is almost closed in the proximal edge.There was no scheduled re-intervention confirmed or how this patient will be treated going forward.No additional information provided.
 
Manufacturer Narrative
Based on the clinical assessment performed the reported type iiia endoleak complaint is refuted rather there is type ia endoleak.The infra renal superior stent margin cuff collapse complaint is confirmed.The root cause is most likely user related (off-label neck angulation).The procedure related harms for this complaint could not be determined based on the information shared with endologix to review.The final patient status was not reported.The devices remain implanted in the patient and will not be returned; therefore, device evaluation will not be completed.The review of manufacturing lot confirmed all devices met specifications prior to release.This complaint is not capa eligible at this time.These types of events will be monitored and trended as part of the quality system.
 
Event Description
Subsequent to the previously submitted report, additional information was received reporting that there a secondary treatment was performed; however, detailed information is unknown.No additional information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
MDR Report Key7429257
MDR Text Key105417735
Report Number2031527-2018-00325
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009014726
UDI-Public(01)00818009014726(17)180905
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 03/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date09/05/2018
Device Model NumberBEA25-100/I16-40
Device Catalogue NumberF00820-34
Device Lot Number1736407013
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/22/2018
Initial Date FDA Received04/13/2018
Supplement Dates Manufacturer Received08/09/2018
Supplement Dates FDA Received12/17/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
VELA INFRARENAL, LOT 1625010022; VELA INFRARENAL, LOT 1625010022
Patient Outcome(s) Required Intervention;
-
-